Prevalensi dan sebaran faktor risiko anemia pada pasien hepatitis C kronik yang menjalani terapi kombinasi interferon alfa dan ribavirin = Prevalence anaemia and risk factor distribution in patients with chronic hepatitis C who received interferon alfa and ribavirin combination therapy

Hubungan SNP IL-28B Pejamu dengan Respons Virologis Menetap serta Kaitannya dengan Ekspresi Interferon-3 dan Reseptor Interferon-λ3 di Jaringan Hati pada Pasien Hepatitis C Kronik dengan Pengobatan Pegylated Interferon Α2 dan Ribavirin = Association between SNP IL-28B and Sustained Virological Response and Its Relation with Expression of Interferon Lambda-3 and Interferon Lambda-3 Receptor in Liver Tissues of Chronic Hepatitis C Patients Treated with Pegylated Interferon α2 and Ribavirin

Hubungan SNP IL-28B Pejamu dengan Respons Virologis Menetap serta Kaitannya dengan Ekspresi Interferon-3 dan Reseptor Interferon-λ3 di Jaringan Hati pada Pasien Hepatitis C Kronik dengan Pengobatan Pegylated Interferon Α2 dan Ribavirin = Association between SNP IL-28B and Sustained Virological Response and Its Relation with Expression of Interferon Lambda-3 and Interferon Lambda-3 Receptor in Liver Tissues of Chronic Hepatitis C Patients Treated with Pegylated Interferon α2 and Ribavirin

The role of hepatitis c virus ns5a region mutation and snp il-28b of host to support successful pegylated interferon and ribavirin treatment in patients with hcv-hiv coinfection: A prospective cohort study

Peran Mutasi Regio NS5A Virus Hepatitis C dan SNP IL-28B Pejamu terhadap Keberhasilan Terapi Pegylated Interferon dan Ribavirin pada Pasien Koinfeksi VHC-HIV = The Role of Mutation of Hepatitis C Virus NS5A Region and SNP IL-28B of Host toward The Successfulness of Pegylated Interferon and Ribavirin Treatment Among Patients with HCV-HIV Co-Infection